Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress-associated endoplasmic reticulum protein 1 (SERP1), also called RAMP4, is an evolutionarily conserved membrane protein of the ER that is upregulated during ER stress and interacts directly with the Sec61 translocon complex[1][2][4]. It stabilizes nascent, unfolded, or misfolded membrane proteins during conditions of cellular stress, preventing their degradation in the ER[1][3][4]. SERP1 regulates aspects of protein translocation and glycosylation, including ensuring the correct processing of secretory and membrane proteins and the glycosylation of MHC class II-associated invariant chains[1][2][4]. Loss of SERP1 function leads to increased ER stress, defective insulin production, and impaired growth hormone response[4]. Clinically, altered expression is associated with cancer prognosis and certain metabolic or endocrine disorders[1][3][4]. SERP1 serves no known receptor, enzyme, or transporter function but is a critical ER scaffolding and quality control protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress-associated endoplasmic reticulum protein 1 (SERP1).